Erythropoietin improves memory function with reducing endothelial dysfunction and amyloid-beta burden in Alzheimer's disease models.
about
Erythropoietin and diabetes mellitusErythropoietin: new directions for the nervous systemShedding new light on neurodegenerative diseases through the mammalian target of rapamycinPost-ischemic continuous infusion of erythropoeitin enhances recovery of lost memory function after global cerebral ischemia in the rat.pH responsive granulocyte colony-stimulating factor variants with implications for treating Alzheimer's disease and other central nervous system disorders.Orexin receptors exert a neuroprotective effect in Alzheimer's disease (AD) via heterodimerization with GPR103Prevention of β-amyloid degeneration of microglia by erythropoietin depends on Wnt1, the PI 3-K/mTOR pathway, Bad, and Bcl-xL.Regeneration in the nervous system with erythropoietinComparative Histological Study on the Therapeutic Effect of Green Tea and Stem Cells in Alzheimer's Disease Complicating Experimentally Induced Diabetes.A Critical Kinase Cascade in Neurological Disorders: PI 3-K, Akt, and mTOR.Oxidant stress and signal transduction in the nervous system with the PI 3-K, Akt, and mTOR cascadeEpidermal growth factor prevents APOE4 and amyloid-beta-induced cognitive and cerebrovascular deficits in female mice.Epobis is a Nonerythropoietic and Neuroprotective Agonist of the Erythropoietin Receptor with Anti-Inflammatory and Memory Enhancing Effects.Safety issues related to erythropoiesis-stimulating agents used to treat anemia in patients with chronic kidney disease.Targeting erythropoietin for chronic neurodegenerative diseases.Erythropoietin as a new therapeutic opportunity in brain inflammation and neurodegenerative diseases.Intranasal delivery of bone marrow-derived mesenchymal stem cells, macrophages, and microglia to the brain in mouse models of Alzheimer's and Parkinson's disease.Glycative Stress and Its Defense Machinery Glyoxalase 1 in Renal Pathogenesis.Erythropoietin and Its Angiogenic Activity.Peripheral Inflammation, Apolipoprotein E4, and Amyloid-β Interact to Induce Cognitive and Cerebrovascular Dysfunction.Erythropoietin Restores Long-Term Neurocognitive Function Involving Mechanisms of Neuronal Plasticity in a Model of Hyperoxia-Induced Preterm Brain Injury.Endothelial dysfunction, macrophage infiltration and NADPH oxidase-dependent superoxide production were attenuated by erythropoietin in streptozotocin-induced diabetic rat aorta.Intranasal formulation of erythropoietin (EPO) showed potent protective activity against amyloid toxicity in the Aβ₂₅₋₃₅ non-transgenic mouse model of Alzheimer's disease.An Intranasal Formulation of Erythropoietin (Neuro-EPO) Prevents Memory Deficits and Amyloid Toxicity in the APPSwe Transgenic Mouse Model of Alzheimer's Disease.Erythropoietin attenuates axonal injury after middle cerebral artery occlusion in mice.Modulation of the expression of genes related to the system of amyloid-beta metabolism in the brain as a novel mechanism of ceftriaxone neuroprotective properties.
P2860
Q26777878-88A37847-CB9F-4A23-9FC0-56DFC7A1413FQ26828425-FF0B004E-C88B-4666-A1FE-C14CE1F93143Q27015640-5E29FA61-3E10-47CB-B732-6B9C5073893EQ31112997-09710DD7-4A1A-48F4-B164-727F12C0F349Q35602819-40EBCCBD-767D-4875-9436-01B56BFDD375Q35902193-D38324ED-CB70-4A62-AF08-D302BD325588Q35947388-1D5847BD-4464-45AC-B247-848C77D0FC2AQ36247651-4BDE335C-B498-47FF-9C44-B5786AA62C0DQ36295484-FA656BE2-E123-441B-8E60-5A3F9E038F92Q36379761-D2D356F1-6A3B-4092-950D-CA818F694B66Q36432388-E4A82E90-8850-414E-8B36-7B7B630DA9C9Q37374629-3C7EC12D-68BC-400E-A744-A793F18FC724Q37471491-C43ACFBA-0A47-484B-A19B-94BAB5036038Q38037120-83A12357-6DC5-455A-AD9E-E4F561AC10CFQ38091151-428A1EE4-759B-4CA6-9B23-09513CBACC89Q38269081-A67C385B-719E-4AB7-8ACF-B8655AE5B969Q38303586-D3984F9E-462E-4E6D-A7AA-468EA874C707Q39096507-0B99195E-601F-4F55-B24B-CBFE91F0628AQ39432541-8B7836E3-E152-48F2-B2F2-BE6C889398ABQ41087339-D88B568E-4CE6-4498-B448-7DDA920B307AQ41775024-5782BCC5-831F-4354-89F9-491A41D0B58BQ43647617-E5028415-BB5A-4A0A-ADA5-83B74D9D2282Q44363046-145B30F9-7E82-4C89-B3C0-0A26304B3913Q48497465-05580D91-995F-4872-A84C-D1FC8EBDB4C5Q51055192-D31D2A97-BD61-4BC8-9F2A-0BE56B71A294Q55346138-6A379721-933A-4673-A2A3-C9BD14A2BDE5
P2860
Erythropoietin improves memory function with reducing endothelial dysfunction and amyloid-beta burden in Alzheimer's disease models.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Erythropoietin improves memory ...... in Alzheimer's disease models.
@en
Erythropoietin improves memory ...... in Alzheimer's disease models.
@nl
type
label
Erythropoietin improves memory ...... in Alzheimer's disease models.
@en
Erythropoietin improves memory ...... in Alzheimer's disease models.
@nl
prefLabel
Erythropoietin improves memory ...... in Alzheimer's disease models.
@en
Erythropoietin improves memory ...... in Alzheimer's disease models.
@nl
P2093
P2860
P1476
Erythropoietin improves memory ...... in Alzheimer's disease models.
@en
P2093
Daejong Jeon
Jae-Kyu Roh
Ji-Youn Lim
Jung-Eun Park
Keun-Hwa Jung
Sang Kun Lee
Soon-Tae Lee
P2860
P304
P356
10.1111/J.1471-4159.2011.07534.X
P407
P577
2011-11-11T00:00:00Z